Looking to the future of cancer immunotherapy: many questions to answer and many therapeutic opportunities Suzanne Ostrand-Rosenberg Editorial 20 December 2012 Pages: 1 - 2
High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function Gabriela A. PizzurroFlorencia P. Madorsky RowdoJosé Mordoh Original article 22 June 2012 Pages: 3 - 15
FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma Lotte Engell-NoerregaardHelle W. HendelInge Marie Svane Original article 22 June 2012 Pages: 17 - 25
T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer Kathrin BauerNina NeliusMatthias Kloor Original Article 23 June 2012 Pages: 27 - 37
Lenalidomide enhances anti-myeloma cellular immunity Katarina LuptakovaJacalyn RosenblattDavid Avigan Original article 24 June 2012 Pages: 39 - 49
T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile Shahryar KiaiiParviz KokhaeiHåkan Mellstedt Original Article 27 June 2012 Pages: 51 - 63
Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients Lili YangBaozhu RenXiubao Ren Original article 29 June 2012 Pages: 65 - 73
Generation and immunologic functions of Th17 cells in malignant gliomas Manjeera PaladuguArchana ThakurPrahlad Parajuli Original article 01 July 2012 Pages: 75 - 86
B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion Yu ZhangYair EliavJoseph D. Rosenblatt Original Article 08 July 2012 Pages: 87 - 99
Distinct in vivo CD8 and CD4 T cell responses against normal and malignant tissues David CoeCaroline AddeyJian-Guo Chai Original article 18 July 2012 Pages: 101 - 112
CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients Mercedes BorgePaula Romina NanniniRomina Gamberale Original article 29 July 2012 Pages: 113 - 124
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma Surasak PhuphanichChristopher J. WheelerJohn S. Yu Original article Open access 31 July 2012 Pages: 125 - 135
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer Nadeem A. SheikhDaniel PetrylakDavid L. Urdal Original article Open access 03 August 2012 Pages: 137 - 147
Memory T cells are uniquely resistant to melanoma-induced suppression Lucy WentworthJustin V. MeyersClifford S. Cho Original Article 04 August 2012 Pages: 149 - 159
Increased prevalence of tumor-infiltrating regulatory T cells is closely related to their lower sensitivity to H2O2-induced apoptosis in gastric and esophageal cancer Shinichirou IzawaKousaku MimuraKoji Kono Original article 04 August 2012 Pages: 161 - 170
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine Shiwen PengSofia Lyford-PikeSara I. Pai Original Article 04 August 2012 Pages: 171 - 182
A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response Shijun KangJianmin XieRongcheng Luo Original article 05 August 2012 Pages: 183 - 190
MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy Fabricio de CarvalhoVeruska L. F. AlvesGisele W. B. Colleoni Short communication 22 November 2012 Pages: 191 - 195
“Tumor Immunology Meets Oncology (TIMO) VIII” from May 4 to 5, 2012, in Halle/Saale, Germany Diana BarthelBarbara Seliger Meeting report 21 November 2012 Pages: 197 - 202
